(Q44644452)

5 December 2017

title

Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study (English)

1 reference

5 December 2017

1 reference

1 reference

Mehran Monchi

1

1 reference

5 December 2017

Denis Berghmans

2

1 reference

5 December 2017

Didier Ledoux

3

1 reference

5 December 2017

Jean-Luc Canivet

4

1 reference

5 December 2017

Bernard Dubois

5

1 reference

5 December 2017

Pierre Damas

6

1 reference

5 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14600809

29 March 2024

publication date

5 November 2003

1 reference

full work available at URL

5 December 2017

http://link.springer.com/article/10.1007/s00134-003-2047-x/fulltext.html

1 reference

https://api.crossref.org/works/10.1007/S00134-003-2047-X

http://link.springer.com/content/pdf/10.1007/s00134-003-2047-x.pdf

29 March 2024

file format

Portable Document Format

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00134-003-2047-X

http://link.springer.com/content/pdf/10.1007/s00134-003-2047-x

29 March 2024

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00134-003-2047-X

29 March 2024

published in

Intensive Care Medicine

1 reference

5 December 2017

volume

30

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

260-265

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-003-2047-x

5 December 2017

exact match

0 references

cites work

Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge

1 reference

12 December 2020

Nafamostat Mesylate as Anticoagulant in Continuous Hemofiltration and Continuous Hemodiafiltration

1 reference

12 December 2020

Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding

1 reference

12 December 2020

Transfusion requirements during continuous veno-venous haemofiltration: -the importance of filter life.

1 reference

12 December 2020

Continuous veno-venous hemofiltration without anticoagulation in high-risk patients.

1 reference

12 December 2020

Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial

1 reference

12 December 2020

The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group.

1 reference

12 December 2020

Simplified citrate anticoagulation for continuous renal replacement therapy

1 reference

12 December 2020

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

1 reference

12 December 2020

A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration

1 reference

12 December 2020

Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent

1 reference

12 December 2020

Extracorporeal management of acute renal failure patients at high risk of bleeding

1 reference

12 December 2020

Regional citrate anticoagulation in continuous venovenous hemodiafiltration.

1 reference

12 December 2020

Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients

1 reference

12 December 2020

Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration

1 reference

12 December 2020

A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study

14

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00134-003-2047-X

29 March 2024

Identifiers

1 reference

5 December 2017

1 reference